IMMUcan reaches 1500 Patients enrolled
The IMMUcan project has successfully reached a major milestone by [...]
300 Patients Registered for the Bioradon Study
The EORTC 1920 BIORADON team is pleased to announce that [...]
2000 Patients Enrolled on the SPECTA Platform
We are thrilled to announce that a major milestone was [...]
Arcagen project recruitment is now complete
We are happy to announce that we finished patient recruitment [...]
EORTC and Alliance Healthcare’s continued partnership
Brussels, May 19, 2022 – The European Organisation for Research [...]
SPECTA RP-1920 Bioradon is now open for recruitment in France!
The primary objective of this study is to assess the [...]
Independent Clinical Cancer Research in the Continuum
Access to innovative cancer therapies is hampered by limited clinically [...]
The 1553-SPECTA translational research
The 1553-SPECTA translational research platform registered the 1000th patient on [...]
European Cancer Summit supports a reorientation
Br Mary Rice, EORTC Communication Consultant TheEuropean Cancer Summit, organised [...]
EORTC SPECTA platform identifies genetic alterations
On 24 October 2020 in the virtual 32nd EORTC-NCI-AACR symposium [...]
